Data show that simufilam reduced seizure activity in a preclinical mouse model Presentation also highlights favorable human safety data fro ...

Removing 10 per cent of a patient’s blood before major liver surgery and giving it back afterwards reduced transfusions by ...

Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...

The cost of a bad hire can be devastating for a small business. This is the story of my biggest hiring disaster and the red flags I wish I'd recognized earlier.

The Launch-HTN trial is the largest trial of an aldosterone synthase inhibitor completed in participants with uncontrolled or treatment resistant hypertension – – Lorundrostat 50 mg once daily ...

Clinical trials are an essential step in medical science; they are the key. They serve to answer questions about the safety ...

Perfuse Therapeutics is conducting trials for the treatment for glaucoma and diabetic retinopathy, aiming to restore vision ...

The shift reflects more than a funding gap - it signals a structural realignment in how cancer breakthroughs may be brought to market. As public systems face pressure and timelines extend, nimble ...

Results from the Phase III BASIS trial show that once-weekly subcutaneous Hympavzi reduced annualized bleeding rates by 93% ...

Baystreet.ca News Commentary – As cancer rates continue to climb worldwide, the race to develop better, faster, and more ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...